Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of preterm birth
3.2.1.2 Advancements in maternal and fetal care
3.2.1.3 Increased awareness of preterm birth risk factors
3.2.1.4 Rising government initiatives and funding
3.2.2 Industry pitfalls and challenges
3.2.2.1 Side effects and safety concerns
3.2.2.2 Potential competition from generic drugs
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Pipeline analysis
3.7 Gap analysis
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Future market trends
3.11 Value chain analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Therapy Type, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Progesterone therapy
5.3 Corticosteroid therapy
5.4 Tocolytic therapy
5.5 Antibiotics therapy
5.6 Heparin prophylaxis therapy
5.7 Other therapy types
Chapter 6 Market Estimates and Forecast, By Route of Administration, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Parenteral
6.3 Oral
6.4 Topical
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Brick and mortar
7.3 E-commerce
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 AbbVie
9.2 AMAG Pharmaceuticals
9.3 Ferring Pharmaceutical
9.4 Merck
9.5 Obseva
9.6 Pfizer
9.7 Takeda Pharmaceutical
